Presence of brain pathology in deceased subjects with and without chronic obstructive pulmonary disease

Chronic Respiratory Disease

Volumn 12, Issue 4, 2015, Pages 284-290

  Cleutjens, Fiona A H M ^a   Spruit, Martijn A ^a   Beckervordersandforth, Jan ^b   Franssen, Frits M E ^a   Dijkstra, Jeanette B ^c   Ponds, Rudolf W H M ^c   Wouters, Emiel F M ^a,b   Janssen, Daisy J A ^a  

^a Centre of Expertise for Chronic Organ Failure   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

brain; cognition; COPD; hypoxaemia; Netherlands Brain Bank; neuropathology

Indexed keywords

AGED; ARTICLE; AUTOPSY; BRAIN DEGENERATION; BRAIN DISEASE; BRAIN TUMOR; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; BRAIN; BRAIN NEOPLASMS; CASE CONTROL STUDY; CEREBROVASCULAR DISORDERS; COMORBIDITY; NETHERLANDS; NEURODEGENERATIVE DISEASES; ODDS RATIO; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUTOPSY; BRAIN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NETHERLANDS; NEURODEGENERATIVE DISEASES; ODDS RATIO; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 84944052814     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972315588005     Document Type: Article

References (44)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187 (4): 347-365.
2. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187 (7): 728-735.
3. Cleutjens F, Spruit M, Ponds R, et al. Cognitive functioning in obstructive lung disease: results from the UK biobank. JAMDA 15 (3): 214-219.
4. Dodd JW, Getov SV, Jones PW,. Cognitive function in COPD. Eur Respir J 2010; 35 (4): 913-922.
5. Hynninen KM, Breitve MH, Wiborg AB, et al. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 2005; 59 (6): 429-443.
6. Schillerstrom JE, Horton MS, Royall DR,. The impact of medical illness on executive function. Psychosomatics 2005; 46 (6): 508-516.
7. Zhang H, Wang X, Lin J, et al. Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study. BMJ Open 2012; 2 (2): e000844.
8. Zhang H, Wang X, Lin J, et al. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study. AJNR Am J Neuroradiol 2013; 34 (2): 334-339.
9. Dodd JW, Chung AW, van den Broek MD, et al. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med 2012; 186 (3): 240-245.
10. Li J, Fei GH,. The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease. Respir Res 2013; 14: 140.
11. Kent BD, Mitchell PD, McNicholas WT,. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011; 6: 199-208.
12. Zhang H, Wang X, Lin J, et al. Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study. AJNR Am J Neuroradiol 2013; 34 (2): 334-339.
13. Antonelli Incalzi R, Marra C, Giordano A, et al. Cognitive impairment in chronic obstructive pulmonary disease-a neuropsychological and spect study. J Neurol 2003; 250 (3): 325-332.
14. Huang C, Wahlund LO, Almkvist O, et al. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. NeuroImage 2003; 19 (3): 1137-1144.
15. Ortapamuk H, Naldoken S,. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 2006; 20 (2): 99-106.
16. van Dijk EJ, Vermeer SE, de Groot JC, et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2004; 75 (5): 733-736.
17. Grant I, Prigatano GP, Heaton RK, et al. Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry 1987; 44 (11): 999-1006.
18. Borson S, Scanlan J, Friedman S, et al. Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis 2008; 3 (3): 429-434.
19. Bank TNB. Information for tissue applicants., http://www.brainbank.nl/media/uploads/file/Information%20for%20tissue%20applicants-2013.pdf (. 2014, accessed 10 October 2013).
20. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (5): 373-383.
21. Braak H, Braak E,. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82 (4): 239-259.
22. DHoore W, Sicotte C, Tilquin C,. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993; 32 (5): 382-387.
23. Dirnagl U, Iadecola C, Moskowitz MA,. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22 (9): 391-397.
24. Goldstein LB, Samsa GP, Matchar DB, et al. Charlson index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004; 35 (8): 1941-1945.
25. Taraszewska A, Zelman IB, Ogonowska W, et al. The pattern of irreversible brain changes after cardiac arrest in humans. Folia Neuropathol 2002; 40 (3): 133-141.
26. Erecinska M, Silver IA,. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol 2001; 128 (3): 263-276.
27. Prayson RA,. Neuropathology. 2nd ed. Philadelphia: Elsevier, 2012.
28. Barbera JA, Roca J, Ferrer A, et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997; 10 (6): 1285-1291.
29. Dealberto MJ, Pajot N, Courbon D, et al. Breathing disorders during sleep and cognitive performance in an older community sample: the EVA Study. J Am Geriatr Soc 1996; 44 (11): 1287-1294.
30. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180 (6): 506-512.
31. Baezner H, Blahak C, Poggesi A, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008; 70 (12): 935-942.
32. Starr JM, Leaper SA, Murray AD, et al. Brain white matter lesions detected by magnetic resonance [correction of resonance] imaging are associated with balance and gait speed. J Neurol Neurosurg Psychiatry 2003; 74 (1): 94-98.
33. Whitman GT, Tang Y, Lin A, et al. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001; 57 (6): 990-994.
34. Ainslie PN, Ogoh S,. Regulation of cerebral blood flow in mammals during chronic hypoxia: a matter of balance. Exp Physiol 2010; 95 (2): 251-262.
35. Albayrak R, Fidan F, Unlu M, et al. Extracranial carotid Doppler ultrasound evaluation of cerebral blood flow volume in COPD patients. Respir Med 2006; 100 (10): 1826-1833.
36. Vogiatzis I, Louvaris Z, Habazettl H, et al. Cerebral cortex oxygen delivery and exercise limitation in patients with COPD. Eur Respir J 2013; 41 (2): 295-301.
37. Payen JF, LeBars E, Wuyam B, et al. Lactate accumulation during moderate hypoxic hypoxia in neocortical rat brain. J Cereb Blood Flow Metab 1996; 16 (6): 1345-1352.
38. Leverve XM,. Energy metabolism in critically ill patients: lactate is a major oxidizable substrate. Curr Opin Clin Nutr Metab Care 1999; 2 (2): 165-169.
39. Rahaghi FN, van Beek EJ, Washko GR,. Cardiopulmonary coupling in chronic obstructive pulmonary disease: the role of imaging. J Thorac Imaging 2014; 29 (2): 80-91.
40. Amsterdam EA, Schaefer S,. Ischemic preconditioning in coronary heart disease: a therapeutic golden fleece? J Am Coll Cardiol 2004; 43 (9): 1515-1516.
41. Liu XQ, Sheng R, Qin ZH,. The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin 2009; 30 (8): 1071-1080.
42. Thompson JW, Dave KR, Young JI, et al. Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance. Neurotherapeutics 2013; 10 (4): 789-797.
43. Tsuang D, Simpson KL, Li G, et al. Evaluation of selection bias in an incident-based dementia autopsy case series. Alzheimer Dis Assoc Disord 2005; 19 (2): 67-73.
44. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28 (6): 1245-1257.